Biomarkers for diagnosis of neonatal sepsis: a literature review

References

• Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367–389.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
   PubMed Web of Science ®Google Scholar
• Rajaratnam JK, Marcus JR, Flaxman AD, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet. 2010;375:1988–2008.
   PubMed Web of Science ®Google Scholar
• Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:957–979.
   PubMed Web of Science ®Google Scholar
• van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, et al. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010;97:22–28.
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics. 2010;125:e1031–e1038.
   PubMed Web of Science ®Google Scholar
• Bailit JL, Gregory KD, Reddy UM, et al. Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol. 2010;202:245.e1–245.e12.
   PubMed Web of Science ®Google Scholar
• Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937–941.
   PubMed Web of Science ®Google Scholar
• Borghesi A, Tzialla C, Decembrino L, et al. New possibilities of prevention of infection in the newborn. J Matern-Fetal Neonatal Med. 2011;24(Suppl 2):28–30.
   PubMed Web of Science ®Google Scholar
• Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect. 2008;68:293–300.
   PubMed Web of Science ®Google Scholar
• Brady MT. Health care-associated infections in the neonatal intensive care unit. Am J Infect Control. 2005;33:268–275.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Decembrino L, Gallo E, et al. [Recent advances in prevention of sepsis in the preterm neonate]. Recenti Prog Med. 2010;101:483–489.
   PubMedGoogle Scholar
• Kirpal H, Gathwala G, Chaudhary U, et al. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial. J Matern-Fetal Neonatal Med. 2016;29:624–628.
   PubMed Web of Science ®Google Scholar
• Cleminson J, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2015;10:CD003850.
   PubMed Web of Science ®Google Scholar
• Gupta B, Vaswani ND, Sharma D, et al. Evaluation of efficacy of skin cleansing with chlorhexidine in prevention of neonatal nosocomial sepsis: a randomised controlled trial. J Matern-Fetal Neonatal Med. 2016;29:242–247.
   PubMed Web of Science ®Google Scholar
• Sharma D, Gathwala G. Impact of chlorhexidine cleansing of the umbilical cord on cord separation time and neonatal mortality in comparison to dry cord care: a nursery-based randomized controlled trial. J Matern-Fetal Neonatal Med. 2014;27:1262–1265.
   PubMed Web of Science ®Google Scholar
• Gathwala G, Sharma D, Bhakhri B. kiran Effect of topical application of chlorhexidine for umbilical cord care in comparison with conventional dry cord care on the risk of neonatal sepsis: a randomized controlled trial. J Trop Pediatr. 2013;59:209–213.
   PubMed Web of Science ®Google Scholar
• Sharma DK, Gathwala G, Shastri S. Chlorhexidine- A novel intervention to decrease the nursery stay and antibiotic exposure duration: randomized trial. J Matern-Fetal Neonatal Med. 2016;29:213–217.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev. 2003;CD003312.
   PubMedGoogle Scholar
• Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001;285:413–420.
   PubMed Web of Science ®Google Scholar
• Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Lancet. 2000;355:451–455.
   PubMed Web of Science ®Google Scholar
• Polinski C. The value of the white blood cell count and differential in the prediction of neonatal sepsis. Neonatal Netw. 1996;15:13–23.
   PubMedGoogle Scholar
• Bizzarro MJ, Raskind C, Baltimore RS, et al. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005;116:595–602.
   PubMed Web of Science ®Google Scholar
• Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect. 2014;68(Suppl 1):S24–S32.
   PubMed Web of Science ®Google Scholar
• Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61:1–13.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291.
   PubMed Web of Science ®Google Scholar
• Wattal C, Oberoi JK. Neonatal sepsis. Indian J Pediatr. 2011;78:473–474.
   PubMed Web of Science ®Google Scholar
• Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Isr J Med Sci. 1994;30:430–441.
   PubMedGoogle Scholar
• Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol. 1991;18:361–381.
   PubMed Web of Science ®Google Scholar
• Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am. 2004;51:939–959. (viii–ix).
   PubMed Web of Science ®Google Scholar
• Tosson AMS, Speer CP. Microbial pathogens causative of neonatal sepsis in Arabic countries. J Matern Fetal Neonatal Med. 2011;24:990–994.
   PubMed Web of Science ®Google Scholar
• Sharma D, Patel A, Soni P, et al. Empedobacter brevis meningitis in a neonate: a very rare case of neonatal meningitis and literature review. Case Rep Pediatr. 2016;2016:7609602.
   PubMed Web of Science ®Google Scholar
• Sharma D, Sharma P, Soni P, et al. Ralstonia picketti neonatal sepsis: a case report. BMC Res Notes. 2017;10:28.
   PubMedGoogle Scholar
• Sharma D, Patel A, Soni P, et al. Leminorella sepsis in very low birth weight neonate as cause of neonatal mortality. J Matern-Fetal Neonatal Med. 2017;30:1057–1059.
   PubMed Web of Science ®Google Scholar
• Sharma D, Dasi T, Murki S, et al. Kluyvera ascorbata sepsis in an extremely low birth weight infant. Indian J Med Microbiol. 2015;33:437–439.
   PubMedGoogle Scholar
• Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.
   PubMedGoogle Scholar
• Kellogg JA, Ferrentino FL, Goodstein MH, et al. Frequency of low level bacteremia in infants from birth to two months of age. Pediatr Infect Dis J. 1997;16:381–385.
   PubMed Web of Science ®Google Scholar
• Hedegaard SS, Wisborg K, Hvas A-M. Diagnostic utility of biomarkers for neonatal sepsis-a systematic review. Infect Dis (Lond). 2015;47:117–124.
   PubMed Web of Science ®Google Scholar
• Hendricks-Munoz K, Xu J, Mally P. Biomarkers for neonatal sepsis: recent developments [Internet]. Res Rep Neonatol. 2014;2014:157–168.
   Google Scholar
• Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:16–19.
   PubMed Web of Science ®Google Scholar
• Rozycki HJ, Stahl GE, Baumgart S. Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis. Pediatr Infect Dis J. 1987;6:440–442.
   PubMed Web of Science ®Google Scholar
• Christensen RD, Rothstein G, Hill HR, et al. Fatal early onset group B streptococcal sepsis with normal leukocyte counts. Pediatr Infect Dis. 1985;4:242–245.
   PubMedGoogle Scholar
• Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88(Suppl 2):S69–S74.
   PubMed Web of Science ®Google Scholar
• Schmutz N, Henry E, Jopling J, et al. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol. 2008;28:275–281.
   PubMed Web of Science ®Google Scholar
• Polin RA. Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–1015.
   PubMed Web of Science ®Google Scholar
• Manroe BL, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr. 1979;95:89–98.
   PubMed Web of Science ®Google Scholar
• Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J. 1995;14:362–366.
   PubMed Web of Science ®Google Scholar
• Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:799–802.
   PubMed Web of Science ®Google Scholar
• Philip AG, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics. 1980;65:1036–1041.
   PubMed Web of Science ®Google Scholar
• Ismail AQT, Gandhi A. Using CRP in neonatal practice. J Matern Fetal Neonatal Med. 2015;28:3–6.
   PubMed Web of Science ®Google Scholar
• Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med. 1999;17:1019–1025.
   PubMed Web of Science ®Google Scholar
• Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16:735–747.
   PubMed Web of Science ®Google Scholar
• Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology. 1991;183:133–145.
   PubMed Web of Science ®Google Scholar
• Hofer N, Zacharias E, Müller W, et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102:25–36.
   PubMed Web of Science ®Google Scholar
• Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics. 1993;92:431–435.
   PubMed Web of Science ®Google Scholar
• Franz AR, Steinbach G, Kron M, et al. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics. 1999;104:447–453.
   PubMed Web of Science ®Google Scholar
• Kawamura M, Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr. 1995;84:10–13.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol. 2010;37:421–438.
   PubMed Web of Science ®Google Scholar
• Mussap M. Laboratory medicine in neonatal sepsis and inflammation. J Matern Fetal Neonatal Med. 2012;25(Suppl 4):24–26.
   Web of Science ®Google Scholar
• Wasunna A, Whitelaw A, Gallimore R, et al. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr. 1990;149:424–427.
   PubMed Web of Science ®Google Scholar
• Edgar JDM, Gabriel V, Gallimore JR, et al. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr. 2010;10:22.
   PubMed Web of Science ®Google Scholar
• Abdollahi A, Shoar S, Nayyeri F, et al. Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis. 2012;4:e2012028.
   PubMedGoogle Scholar
• Ganesan P, Shanmugam P, Sattar SBA, et al. Evaluation of IL-6, CRP and hs-CRP as Early Markers of Neonatal Sepsis. J Clin Diagn Res. 2016;10:DC13–DC17.
   PubMed Web of Science ®Google Scholar
• Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38:483–493.
   PubMed Web of Science ®Google Scholar
• Russwurm S, Wiederhold M, Oberhoffer M, et al. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med. 1999;37:789–797.
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–1608.
   PubMed Web of Science ®Google Scholar
• Hahn W-H, Song J-H, Park I-S, et al. Reference intervals of serum procalcitonin are affected by postnatal age in very low birth weight infants during the first 60 days after birth. Neonatology. 2015;108:60–64.
   PubMed Web of Science ®Google Scholar
• Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–672.
   PubMed Web of Science ®Google Scholar
• Chiesa C, Pellegrini G, Panero A, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem. 2003;49:60–68.
   PubMed Web of Science ®Google Scholar
• Assumma M, Signore F, Pacifico L, et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem. 2000;46:1583–1587.
   PubMed Web of Science ®Google Scholar
• Lee J, Bang YH, Lee EH, et al. The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life. Korean J Pediatr. 2017;60:10–16.
   PubMedGoogle Scholar
• Kordek A, Łoniewska B, Podraza W, et al. Usefulness of estimation of blood procalcitonin concentration versus C-reactive protein concentration and white blood cell count for therapeutic monitoring of sepsis in neonates. Postepy Hig Med Dosw. 2014;68:1516–1523.
   Web of Science ®Google Scholar
• Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737–1741.
   PubMed Web of Science ®Google Scholar
• Hahn W-H, Song J-H, Kim H, et al. Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis? J Matern Fetal Neonatal Med. 2017;0:1–5.
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426–435.
   PubMed Web of Science ®Google Scholar
• Yuan H, Huang J, Lv B, et al. Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis. Biomed Res Int. 2013;2013:520294.
   PubMed Web of Science ®Google Scholar
• Lannergård A, Friman G, Ewald U, et al. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr (Oslo Nor 1992). 2005;94:1198–1202.
   PubMed Web of Science ®Google Scholar
• Arnon S, Litmanovitz I, Regev R, et al. The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. J Perinat Med. 2004;32:176–180.
   PubMed Web of Science ®Google Scholar
• Arnon S, Litmanovitz I, Regev R, et al. Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate. 2005;87:105–110.
   PubMedGoogle Scholar
• Arnon S, Litmanovitz I, Regev RH, et al. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J Perinatol. 2007;27:297–302.
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Köksal N, et al. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2009;29:225–231.
   PubMed Web of Science ®Google Scholar
• Behrendt D, Dembinski J, Heep A, et al. Lipopolysaccharide binding protein in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F551–F554.
   PubMed Web of Science ®Google Scholar
• Delsesto D, Opal SM. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis. Contrib Microbiol. 2011;17:137–156.
   PubMedGoogle Scholar
• Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med. 2004;30:1454–1460.
   PubMed Web of Science ®Google Scholar
• Turner D, Hammerman C, Rudensky B, et al. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 2006;91:F283–F286.
   PubMed Web of Science ®Google Scholar
• D’Alquen D, Kramer BW, Seidenspinner S, et al. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res. 2005;57:263–269.
   PubMed Web of Science ®Google Scholar
• Berner R, Fürll B, Stelter F, et al. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol. 2002;9:440–445.
   PubMedGoogle Scholar
• Kishimoto T. The biology of interleukin-6. Blood. 1989;74:1–10.
   PubMed Web of Science ®Google Scholar
• Hodge G, Hodge S, Han P, et al. Multiple leucocyte activation markers to detect neonatal infection. Clin Exp Immunol. 2004;135:125–129.
   PubMed Web of Science ®Google Scholar
• Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324:73–76.
   PubMed Web of Science ®Google Scholar
• Raynor LL, Saucerman JJ, Akinola MO, et al. Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res. 2012;71:261–266.
   PubMed Web of Science ®Google Scholar
• Küster H, Weiss M, Willeitner AE, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet (Lond Engl). 1998;352:1271–1277.
   PubMed Web of Science ®Google Scholar
• Smulian JC, Vintzileos AM, Lai YL, et al. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J Matern Fetal Med. 1999;8:88–94.
   PubMedGoogle Scholar
• Smulian JC, Bhandari V, Campbell WA, et al. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Matern Fetal Neonatal Med. 1997;6:254–259.
   Google Scholar
• Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J. 2000;19:879–887.
   PubMed Web of Science ®Google Scholar
• Cernada M, Badía N, Modesto V, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr. 2012;101:e203–e207.
   PubMed Web of Science ®Google Scholar
• Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr. 2006;18:125–131.
   PubMed Web of Science ®Google Scholar
• Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. SPAE. 1999;88:647–650.
   Web of Science ®Google Scholar
• Hou T, Huang D, Zeng R, et al. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8:15238–15245.
   PubMed Web of Science ®Google Scholar
• Reinsberg J, Dembinski J, Dorn C, et al. Determination of total interleukin-8 in whole blood after cell lysis. Clin Chem. 2000;46:1387–1394.
   PubMed Web of Science ®Google Scholar
• Franz AR, Sieber S, Pohlandt F, M K, G S. Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection. Acta Paediatr (Oslo Nor 1992). 2004;93:648–653.
   PubMed Web of Science ®Google Scholar
• Resch B, Gusenleitner W, Müller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. 2003;92:243–245.
   PubMed Web of Science ®Google Scholar
• Mishra UK, Jacobs SE, Doyle LW, et al. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed. 2006;91:F208–F212.
   PubMed Web of Science ®Google Scholar
• Boskabadi H, Maamouri G, Afshari JT, et al. Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis. Iran J Pediatr. 2010;20:41–47.
   PubMed Web of Science ®Google Scholar
• Boskabadi H, Maamouri G, Tavakol Afshari J, et al. Evaluation of serum interleukins-6, 8 and 10 levels as diagnostic markers of neonatal infection and possibility of mortality. Iran J Basic Med Sci 2013;16:1232–1237.
   PubMed Web of Science ®Google Scholar
• Kocabaş E, Sarikçioğlu A, Aksaray N, et al. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr. 2007;49:7–20.
   PubMed Web of Science ®Google Scholar
• Zhou M, Cheng S, Yu J, et al. Interleukin-8 for diagnosis of neonatal sepsis: a meta-analysis. PloS One. 2015;10:e0127170.
   PubMed Web of Science ®Google Scholar
• Berner R, Niemeyer CM, Leititis JU, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res. 1998;44:469–477.
   PubMed Web of Science ®Google Scholar
• Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1997;77:F221–F227.
   PubMed Web of Science ®Google Scholar
• de Bont ES, Martens A, van Raan J, et al. Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr. 1994;83:696–699.
   PubMed Web of Science ®Google Scholar
• Lv B, Huang J, Yuan H, et al. Tumor necrosis factor-α as a diagnostic marker for neonatal sepsis: a meta-analysis. Scientific World J. 2014;2014:471463.
   Web of Science ®Google Scholar
• Weirich E, Rabin RL, Maldonado Y, et al. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr. 1998;132:445–451.
   PubMed Web of Science ®Google Scholar
• Nupponen I, Andersson S, Järvenpää AL, et al. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics. 2001;108:E12
   PubMed Web of Science ®Google Scholar
• Adib M, Ostadi V, Navaei F, et al. Evaluation of CD11b expression on peripheral blood neutrophils for early detection of neonatal sepsis. Iran J Allergy Asthma Immunol. 2007;6:93–96.
   PubMed Web of Science ®Google Scholar
• Graversen JH, Madsen M, Moestrup SK. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol. 2002;34:309–314.
   PubMed Web of Science ®Google Scholar
• Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology. 2005;210:153–160.
   PubMed Web of Science ®Google Scholar
• Prashant A, Vishwanath P, Kulkarni P, et al. Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study. PLoS One. 2013;8:e68426.
   PubMed Web of Science ®Google Scholar
• Garlanda C, Bottazzi B, Bastone A, et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337–366.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Garlanda C, Doni A, et al. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 2008;28:1–13.
   PubMed Web of Science ®Google Scholar
• Sprong T, Peri G, Neeleman C, et al. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock. 2009;31:28–32.
   PubMed Web of Science ®Google Scholar
• Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006;27:552–558.
   PubMed Web of Science ®Google Scholar
• Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006;12:235–239.
   PubMed Web of Science ®Google Scholar
• Mussap M, Cibecchini F, Noto A, et al. In search of biomarkers for diagnosing and managing neonatal sepsis: the role of angiopoietins. J Matern Fetal Neonatal Med. 2013;26(Suppl 2):24–26.
   PubMed Web of Science ®Google Scholar
• Mankhambo LA, Banda DL, Study Group IPD, Jeffers G, et al. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care (Lond Engl). 2010;14:R91.
   PubMed Web of Science ®Google Scholar
• Ni W, Han Y, Zhao J, et al. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis. Sci Rep. 2016;6:39481.
   PubMed Web of Science ®Google Scholar
• Huttunen R, Syrjänen J, Vuento R, et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med. 2011;270:32–40.
   PubMed Web of Science ®Google Scholar
• Siahanidou T, Margeli A, Tsirogianni C, et al. Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study. Mediators Inflamm. 2014;2014:375702.
   PubMed Web of Science ®Google Scholar
• Okulu E, Arsan S, Akin IM, et al. Serum levels of soluble urokinase plasminogen activator receptor in infants with late-onset sepsis. J Clin Lab Anal. 2015;29:347–352.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang F, Fan X, et al. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 2012;16:R229.
   PubMed Web of Science ®Google Scholar
• Adly AAM, Ismail EA, Andrawes NG, et al. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine. 2014;65:184–191.
   PubMed Web of Science ®Google Scholar
• Saldir M, Tunc T, Cekmez F, et al. Endocan and soluble triggering receptor expressed on myeloid cells-1 as novel markers for neonatal sepsis. Pediatr Neonatol. 2015;56:415–421.
   PubMed Web of Science ®Google Scholar
• Pontrelli G, De Crescenzo F, Buzzetti R, et al. Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review. Ital J Pediatr. 2016;42:44.
   PubMed Web of Science ®Google Scholar
• Lim Y-P, Bendelja K, Opal SM, et al. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis. 2003;188:919–926.
   PubMed Web of Science ®Google Scholar
• Fries E, Kaczmarczyk A. Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim Pol. 2003;50:735–742.
   PubMed Web of Science ®Google Scholar
• Baek YW, Brokat S, Padbury JF, et al. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr. 2003;143:11–15.
   PubMed Web of Science ®Google Scholar
• Chaaban H, Singh K, Huang J, et al. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr. 2009;154:620–622.e1.
   PubMed Web of Science ®Google Scholar
• Degraeuwe PLJ, Nieman FHM. The diagnostic value of inter-alpha inhibitor proteins for neonatal sepsis. J Pediatr. 2010;156:341. (author reply 341).
   PubMed Web of Science ®Google Scholar
• Tunc T, Cekmez F, Cetinkaya M, et al. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J Matern Fetal Neonatal Med. 2015;28:356–361.
   PubMed Web of Science ®Google Scholar
• Mussap M, Noto A, Fravega M, et al. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern-Fetal Neonatal Med. 2011;24(Suppl 2):12–14.
   PubMed Web of Science ®Google Scholar
• Topcuoglu S, Arslanbuga C, Gursoy T, et al. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med. 2016;29:1834–1839.
   PubMed Web of Science ®Google Scholar
• Aydemir O, Ozcan B, Yucel H, et al. Asymmetric dimethylarginine and l-arginine levels in neonatal sepsis and septic shock. J Matern Fetal Neonatal Med. 2015;28:977–982.
   PubMed Web of Science ®Google Scholar
• Mohamed WAW, Saeed MA. Mannose-binding lectin serum levels in neonatal sepsis and septic shock. J Matern Fetal Neonatal Med. 2012;25:411–414.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Dinleyici EC, Tekin N, et al. Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2010;23:1009–1013.
   PubMed Web of Science ®Google Scholar
• El-Mashad A-R, Elmahdy H, El-Dib M, et al. Can melatonin be used as a marker for neonatal sepsis? J Matern Fetal Neonatal Med. 2016;29:2870–2873.
   PubMed Web of Science ®Google Scholar
• İpek İÖ, Saracoglu M, Bozaykut A. α1-Acid glycoprotein for the early diagnosis of neonatal sepsis. J Matern Fetal Neonatal Med. 2010;23:617–621.
   PubMed Web of Science ®Google Scholar
• Stranieri I, Kanunfre KA, Rodrigues JC, et al. Usefulness of a 16S rDNA real-time PCR to monitor neonatal sepsis and to assist in medical decision to discontinue antibiotics. J Matern Fetal Neonatal Med. 2016;29:2141–2144.
   PubMed Web of Science ®Google Scholar
• Yerlikaya FH, Kurban S, Mehmetoglu I, et al. Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis. J Matern Fetal Neonatal Med. 2014;27:1723–1727.
   PubMed Web of Science ®Google Scholar
• Decembrino L, DeAmici M, Silvestri AD, et al. Plasma lactoferrin levels in newborn preterm infants with sepsis. J Matern Fetal Neonatal Med. 2016;0:1–4.
   PubMed Web of Science ®Google Scholar
• Fanos V, Van den Anker J, Noto A, et al. Metabolomics in neonatology: fact or fiction? Semin Fetal Neonatal Med. 2013;18:3–12.
   PubMed Web of Science ®Google Scholar
• Petrakou E, Mouchtouri A, Levi E, et al. Interleukin-8 and monocyte chemotactic protein-1 mRNA expression in perinatally infected and asphyxiated preterm neonates. Neonatology. 2007;91:107–113.
   PubMed Web of Science ®Google Scholar
• Dessì A, Liori B, Caboni P, et al. Monitoring neonatal fungal infection with metabolomics. J Matern Fetal Neonatal Med. 2014;27(Suppl 2):34–38.
   PubMed Web of Science ®Google Scholar
• Dessì A, Corsello G, Stronati M, et al. New diagnostic possibilities in systemic neonatal infections: metabolomics. Early Hum Dev. 2014;90(Suppl 1):S19–S21.
   PubMed Web of Science ®Google Scholar
• Fanos V, Antonucci R, Barberini L, et al. Clinical application of metabolomics in neonatology. J Matern-Fetal Neonatal Med. 2012;25(Suppl 1):104–109.
   PubMed Web of Science ®Google Scholar